TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial.

Saved in:
Bibliographic Details
Title: TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial.
Authors: Baeksgaard Jensen L; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Yilmaz M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark., Möller S; Odense Patient Data Explorative Network (OPEN), Odense University Hospital, Denmark., Elle IC; Department of Oncology, Odense University Hospital, Denmark., Ladekarl M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Qvortrup C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Pfeiffer P; Department of Oncology, Odense University Hospital, Denmark.
Source: EClinicalMedicine [EClinicalMedicine] 2024 Mar 08; Vol. 70, pp. 102521. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38495525
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baeksgaard+Jensen+L%22">Baeksgaard Jensen L</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Yilmaz+M%22">Yilmaz M</searchLink>; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Nordsmark+M%22">Nordsmark M</searchLink>; Department of Oncology, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Möller+S%22">Möller S</searchLink>; Odense Patient Data Explorative Network (OPEN), Odense University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Elle+IC%22">Elle IC</searchLink>; Department of Oncology, Odense University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Ladekarl+M%22">Ladekarl M</searchLink>; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Qvortrup+C%22">Qvortrup C</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Pfeiffer+P%22">Pfeiffer P</searchLink>; Department of Oncology, Odense University Hospital, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2024 Mar 08; Vol. 70, pp. 102521. <i>Date of Electronic Publication: </i>2024 Mar 08 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38495525
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.eclinm.2024.102521
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102521
    Titles:
      – TitleFull: TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baeksgaard Jensen L
      – PersonEntity:
          Name:
            NameFull: Yilmaz M
      – PersonEntity:
          Name:
            NameFull: Nordsmark M
      – PersonEntity:
          Name:
            NameFull: Möller S
      – PersonEntity:
          Name:
            NameFull: Elle IC
      – PersonEntity:
          Name:
            NameFull: Ladekarl M
      – PersonEntity:
          Name:
            NameFull: Qvortrup C
      – PersonEntity:
          Name:
            NameFull: Pfeiffer P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 03
              Text: 2024 Mar 08
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2589-5370
          Numbering:
            – Type: volume
              Value: 70
          Titles:
            – TitleFull: EClinicalMedicine
              Type: main
ResultId 1